Workflow
Johnson's baby powder
icon
Search documents
J&J Stock Can Fall
Forbes· 2025-10-28 13:25
Johnson & Johnson (JNJ) is currently encountering challenges. Even the largest corporations are not invulnerable. Stocks may plummet unexpectedly, erasing months or even years of profits within weeks. Historical evidence indicates that abrupt market fluctuations can affect any company, regardless of how powerful it appears.SAN ANSELMO, CALIFORNIA - OCTOBER 18: Containers of Johnson's baby powder made by Johnson and Johnson sits on a shelf at Jack's Drug Store on October 18, 2019 in San Anselmo, California. ...
Judge rejects Johnson & Johnson's $10B settlement to end baby powder lawsuits
New York Post· 2025-04-01 14:47
Core Viewpoint - Johnson & Johnson's $10 billion proposal to settle lawsuits related to its talc products has been rejected by a US bankruptcy judge, marking the third failure of the company's bankruptcy strategy in court [1][2][3]. Group 1: Bankruptcy Court Decision - US Bankruptcy Judge Christopher Lopez stated that Johnson & Johnson did not belong in bankruptcy and criticized the proposed settlement for lacking sufficient support from women alleging cancer caused by J&J products [2][3]. - The judge noted that the proposal improperly sought to release legal claims against entities that had not filed for bankruptcy, including retailers and Kenvue, a consumer health business spun off by J&J [3][10]. - Lopez highlighted serious flaws in the voting process conducted by J&J, indicating that many votes collected from plaintiffs' attorneys should not be counted [6][7][9]. Group 2: Company Response and Future Actions - Johnson & Johnson announced it would not appeal the ruling but intends to litigate the claims in court, asserting that the talc claims are meritless [4][11]. - The company faces lawsuits from over 60,000 claimants alleging that its talc products contained asbestos and caused ovarian cancer, with the proposed settlement aimed at resolving these lawsuits [11][12]. - J&J had previously estimated that ovarian cancer patients would receive between $75,000 and $150,000 under the settlement, depending on injury severity and the number of claims [13]. Group 3: Historical Context - Johnson & Johnson has been attempting to resolve these lawsuits through bankruptcy since its first attempt, which has now failed three times [1][5]. - The company stopped selling talc-based baby powder in the US in 2020, switching to a cornstarch product, amid ongoing litigation and safety concerns [11][14].